"Loading..."
  • P3 Diagnostics LLC
    Technology. Antibodies. Peptide Epitopes.
  • Where Antibodies Bind
    Using Technology for the Global Good
  • Meet Our Team

Welcome to P3 Diagnostics

P3 Diagnostics, LLC (“P3”) serves to foster the business development of technology created under the direction of Benjamin Larimer, PhD, and The Larimer Lab.

Current Projects
In March 2020, Dr. Larimer sought to utilize his knowledge of peptides to develop a method of antibody detection for COVID-19 in the human body. In July 2020, a provisional patent was issued.

There are many participants in this testing environment, but our technology is different. This is because rather than using widely available antigens to capture antibodies, Larimer has used his technology to map exactly where a patient's antibodies bind to COVID19. This precision provides a type of “facial recognition” that will maximize sensitivity and specificity, when the rest of the industry is using satellite imaging to identify COVID19 immunity.

P3, in conjunction with Larimer and the University of Alabama-Birmingham, is exploring the different paths which can bring this assay to market most efficiently to create value for those who need an accurate at-home antibody test.

Would you like to contact us today?

Meet Our Team

Chris is a Co-Founder of P3 Diagnostics LLC and serves on its Board of Managers as CEO. Chris has served in numerous financial and operating positions within portfolio companies of private equity sponsors.

Christopher Paule
Co-Founder
cpaule@p3diagnosticsllc.com

Ben is a Co-Founder of P3 Diagnostics LLC and serves on its Board of Managers as Chief Science Officer.

Dr. Benjamin Larimer
Co-Founder
blarimer@p3diagnosticsllc.com

Joe is a Co-Founder of P3 Diagnostics, LLC and serves on its Board of Managers. He is the Principal at Management Support Solutions LLC, a Human Resources consulting company.

F.H. "Joe" Gay
Co-Founder
jgay@p3diagnosticsllc.com

Meet Our Advisors

Eric Lee
Board of Managers
 

Eric has been involved in P3 Diagnostics since its pre-formation discussions, and he currently serves on the Board of Managers in a director and non-attorney advisory role. Eric is an experienced attorney, advisor, and director with a diverse background ranging from military service to Chief Legal Officer. His current roles outside of P3 include Chief Legal Officer, Chief Compliance Officer, Data Privacy Officer, Corporate Secretary, and board roles for a multinational company, as well as board roles for other for-profit and not-for-profit companies. Throughout his career, he has served as a lead advisor for founders, family offices, public and private boards, CEOs, CLOs, management teams, operating partners, and others throughout the corporate lifecycle. He brings a practical approach to growth and development and overall management based on a solid understanding of operational and commercial requirements.

You can learn more about Eric here: https://www.linkedin.com/in/sericlee/

Dr. Garima Arvikar
Advisor
 

Dr. Garima Arvikar is a protein engineer currently working as a Postdoctoral Fellow at the University of Alabama at Birmingham in the laboratory of Dr. Benjamin Larimer. Garima received her PhD in biochemistry from The University of Alabama in Dec 2015. Following completion of her degree, she held a postdoctoral fellowship at McMaster University in the laboratory of Dr. Eric Brown where she worked antimicrobial drug discovery. Her current research focuses on the discovery and engineering of novel single domain antibodies for targeted cancer therapy using phage display technology.

Mike Larimer
Advisor
 

Mike is an advisor and key contributor to the phage analysis. He is a multidimensional database expert with over 25 years of experience in the software industry. He holds an MBA from Illinois State University.

Fritz Zaegel
Advisor
 

Since 2001 Fritz has been president of REPCO Solutions, a family-owned company specializing in the execution of full-service marketing, sales and communications programs, with added solutions for fulfillment, warehousing, logistics and distribution. Fritz joined REPCO in 1989 after earning his MBA from St. John’s University. He has a passion for working with current and new customers, and extensive experience in launching new brands. Under his leadership, REPCO maintains a stellar reputation for its world-class operations, can-do attitude and over-the-top service.

In addition to his role at REPCO, Fritz has served on the regional board of the Young Presidents Organization. He also donates his leadership skills and REPCO support to charity organizations including Backstoppers, The Little Bit Foundation, the St. Louis Police Foundation, Matthews-Dickey Boys’ & Girls’ Club and Catholic Harvest Food Pantry.

You can learn more about Fritz here: https://www.linkedin.com/in/fritz-z-3288363/



 

News – TV/Media Coverage

Video Interview With ABC 33/40 News in Birmingham

January 2021

UAB Professor Invents At-Home COVID-19 Antibodies Test

January 11, 2021

New Test Aids in Monitoring COVID-19 Vaccine Immunity - Medical Design Briefs

January 11, 2021

Widely Used Immune Surveillance Technology: To Help Determine Whether an Individual’s COVID-19 Vaccine is Effective and The  Duration of Protection - Posts Careerengine

January 11, 2021

Researcher Develops Technology to Monitor COVID-19 Vaccine Immunity - The News Chronicle

January 7, 2021

The Development of a Widely Used Immune Surveillance Technology May Help Determine Whether an Individual’s Covid-19 Vaccine  is Effective and How Long the Protection Produced Will Last - Biology Online

January 7, 2021

Technology: COVID-19 Monitoring Assistance - Bollyinside

January 6, 2021

UAB Researcher Creates At-Home Immunity Monitoring Technology for COVID-19 - Homeland Preparedness News
January 6, 2021

Quick and Accurate COVID-19 Test Identifies Neutralizing Antibodies to Aid Vaccine Immunity Monitoring - LabMedica International
January 6, 2021

Scientists are Working on Ways to Test Immunity to Test The Effectiveness of the Vaccine Against COVID-19 - MSN Poland
January 5, 2021

UAB Researcher Develops Technology to Aid COVID-19 Vaccine Immunity Monitoring - Global Health News Wire
January 5, 2021

Researchers Develop Technology to Aid COVID-19 Vaccine Immunity Monitoring - Medical Xpress

January 5, 2021

Researchers Develop Immunity Monitoring to Determine The Efficacy Of COVID-19 Vaccine - Industrial News
January 5, 2021

Scientists are Working on Ways to Test Immunity to Test the Effectiveness of the Vaccine Against COVID-19 - Gazeta.pl
January 5, 2021

UAB Researcher Develops Technology to Aid COVID-19 Vaccine Immunity Monitoring - Agenparl

January 5, 2021

Researchers develop immunity monitoring to determine the efficacy of COVID-19 vaccine - News Medical Life Sciences
January 5, 2021

Researchers develop immunity monitoring to determine the efficacy of COVID-19 vaccine - Sound Health and Lasting Wealth
January 5, 2021

Quick and Accurate COVID-19 Test Identifies Neutralizing Antibodies to Aid Vaccine Immunity Monitoring - HospiMedica
January 6, 2021